Advertisement

European Journal of Clinical Pharmacology

, Volume 75, Issue 11, pp 1619–1620 | Cite as

Response to: Is vancomycin clearance really correlated with hemoglobin? Arguments that it’s not

  • Masayuki ChumaEmail author
  • Makoto Makishima
Letter to the Editor
  • 75 Downloads

Notes

References

  1. 1.
    Chuma M, Makishima M, Imai T, Tochikura N, Suzuki S, Kuwana T, Sawada N, Iwabuchi S, Sekimoto M, Nakayama T, Sakaue T, Kikuchi N, Yoshida Y, Kinoshita K (2019) Relationship between hemoglobin levels and vancomycin clearance in patients with sepsis. Eur J Clin Pharmacol 75(7):929–937.  https://doi.org/10.1007/s00228-019-02661-w CrossRefGoogle Scholar
  2. 2.
    Shimamoto Y, Fukuda T, Tanaka K, Komori K, Sadamitsu D (2013) Systemic inflammatory response syndrome criteria and vancomycin dose requirement in patients with sepsis. Intensive Care Med 39(7):1247–1252.  https://doi.org/10.1007/s00134-013-2909-9 CrossRefPubMedGoogle Scholar
  3. 3.
    Yasuhara M, Iga T, Zenda H, Okumura K, Oguma T, Yano Y, Hori R (1998) Population pharmacokinetics of vancomycin in Japanese adult patients. Ther Drug Monit 20(2):139–148CrossRefGoogle Scholar
  4. 4.
    Revilla N, Martin-Suarez A, Perez MP, Gonzalez FM, Fernandez de Gatta Mdel M (2010) Vancomycin dosing assessment in intensive care unit patients based on a population pharmacokinetic/pharmacodynamic simulation. Br J Clin Pharmacol 70(2):201–212.  https://doi.org/10.1111/j.1365-2125.2010.03679.x CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Nguyen BV, Bota DP, Melot C, Vincent JL (2003) Time course of hemoglobin concentrations in nonbleeding intensive care unit patients. Crit Care Med 31(2):406–410.  https://doi.org/10.1097/01.Ccm.0000048623.00778.3f CrossRefPubMedGoogle Scholar
  6. 6.
    Raimundo M, Crichton S, Syed Y, Martin JR, Beale R, Treacher D, Ostermann M (2015) Low systemic oxygen delivery and BP and risk of progression of early AKI. Clin J Am Soc Nephrol 10(8):1340–1349.  https://doi.org/10.2215/cjn.02780314 CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Armstrong BA, Betzold RD, May AK (2017) Sepsis and septic shock strategies. Surg Clin North Am 97(6):1339–1379.  https://doi.org/10.1016/j.suc.2017.07.003 CrossRefPubMedGoogle Scholar
  8. 8.
    Chuma M, Makishima M, Imai T, Tochikura N, Sakaue T, Kikuchi N, Kinoshita K, Kaburaki M, Yoshida Y (2016) Duration of systemic inflammatory response syndrome influences serum vancomycin concentration in patients with sepsis. Clin Ther 38(12):2598–2609.  https://doi.org/10.1016/j.clinthera.2016.10.009 CrossRefPubMedGoogle Scholar
  9. 9.
    Bury D, Ter Heine R, van de Garde EMW, Nijziel MR, Grouls RJ, Deenen MJ (2019) The effect of neutropenia on the clinical pharmacokinetics of vancomycin in adults. Eur J Clin Pharmacol 75(7):921–928.  https://doi.org/10.1007/s00228-019-02657-6 CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Nakayama T, Chuma M, Tochikura N, Iwabuchi S, Suzuki S, Matsumoto C, Imai T, Hamada T, Nakagawa M, Takahashi H, Uchino Y, Miura K, Iriyama N, Hatta Y, Takei M, Kimura T (2019) Increased arbekacin clearance in patients with febrile neutropenia. Ther Drug Monit.  https://doi.org/10.1097/FTD.0000000000000678

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Clinical Trial Center for Developmental TherapeuticsTokushima University HospitalTokushimaJapan
  2. 2.Division of Biochemistry, Department of Biomedical SciencesNihon University School of MedicineTokyoJapan

Personalised recommendations